CODX vs TFX · rev $3.9M vs P/E 2083, rev $3.05B
Co-Diagnostics, Inc. Common Stock (CODX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
CODX currently screens at market cap $31.4M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the CODX and TFX stock pages for the full models.
Not investment advice.